BioCorRx BICX Estimates

OTC BICX
$0.20 -0.03 (-13.04%)
At close: Sep 25, 2026 · 4:00 PM EDT
Analyst Estimates

BioCorRx Inc. Revenue Estimates

Periods 18
Next Period Q2 26
Consensus 223,285.20

Analysts expect BioCorRx Inc. to report revenue of 223,285.20 for Q2 26, against a range of 214,401.58 to 232,168.82. The most recent reported quarter, Q1 26, came in at 214,539.00, a 2.8% beat against the 208,756.90 consensus.

Metric Q1 23Q2 23Q3 23Q1 25Q2 25Q3 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 40,440.0019,640.0010,140.00130,000.00180,000.00635,224.00214,539.00--------
High Estimate -----208,992.21227,960.86232,168.82257,178.80284,890.05353,619.30323,668.01330,808.21340,962.51609,792.63
Low Estimate -----190,532.19189,552.94214,401.58223,778.70257,870.35302,937.08288,043.17295,117.91303,792.39529,583.93
Consensus Estimate -----199,762.20208,756.90223,285.20240,478.75271,380.20328,278.19305,855.59312,963.06322,377.45569,688.28
Analyst Estimates

BioCorRx Inc. Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q2 26
Consensus -0.05

Analysts expect BioCorRx Inc. to report earnings per share of -0.05 for Q2 26, against a range of -0.05 to -0.05. The most recent reported quarter, Q1 26, came in at -0.05, a 18.6% beat against the -0.06 consensus.

Metric Q1 23Q2 23Q3 23Q1 25Q2 25Q3 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -0.13-0.11-0.10-0.06-0.07-0.11-0.05-------
High Estimate ------0.06-0.06-0.05-0.05-0.05-0.06-0.04-0.04-0.04
Low Estimate ------0.06-0.06-0.05-0.05-0.05-0.06-0.04-0.04-0.04
Consensus Estimate ------0.06-0.06-0.05-0.05-0.05-0.06-0.04-0.04-0.04

BioCorRx Inc. Estimates API

Pull Wall Street consensus for BioCorRx Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=BICX&mode=revenue&api_key=YOUR_API_KEY